Matches in Wikidata for { <http://www.wikidata.org/entity/Q84284316> ?p ?o ?g. }
- Q84284316 description "2012 nî lūn-bûn" @default.
- Q84284316 description "2012年の論文" @default.
- Q84284316 description "2012年学术文章" @default.
- Q84284316 description "2012年学术文章" @default.
- Q84284316 description "2012年学术文章" @default.
- Q84284316 description "2012年学术文章" @default.
- Q84284316 description "2012年学术文章" @default.
- Q84284316 description "2012年学术文章" @default.
- Q84284316 description "2012年學術文章" @default.
- Q84284316 description "2012年學術文章" @default.
- Q84284316 description "2012年學術文章" @default.
- Q84284316 description "2012年學術文章" @default.
- Q84284316 description "2012年學術文章" @default.
- Q84284316 description "2012년 논문" @default.
- Q84284316 description "article científic" @default.
- Q84284316 description "article scientific" @default.
- Q84284316 description "article scientifique" @default.
- Q84284316 description "articol științific" @default.
- Q84284316 description "articolo scientifico" @default.
- Q84284316 description "artigo científico" @default.
- Q84284316 description "artigo científico" @default.
- Q84284316 description "artigo científico" @default.
- Q84284316 description "artikel ilmiah" @default.
- Q84284316 description "artikull shkencor" @default.
- Q84284316 description "artikulong pang-agham" @default.
- Q84284316 description "artykuł naukowy" @default.
- Q84284316 description "artículo científico publicado en 2012" @default.
- Q84284316 description "artículu científicu" @default.
- Q84284316 description "bilimsel makale" @default.
- Q84284316 description "bài báo khoa học" @default.
- Q84284316 description "naučni članak" @default.
- Q84284316 description "scienca artikolo" @default.
- Q84284316 description "scientific article published in June 2012" @default.
- Q84284316 description "scientific article published in June 2012" @default.
- Q84284316 description "scientific article published on 01 June 2012" @default.
- Q84284316 description "teaduslik artikkel" @default.
- Q84284316 description "tieteellinen artikkeli" @default.
- Q84284316 description "tudományos cikk" @default.
- Q84284316 description "vedecký článok" @default.
- Q84284316 description "vetenskaplig artikel" @default.
- Q84284316 description "videnskabelig artikel udgivet juni 2012" @default.
- Q84284316 description "vitenskapelig artikkel" @default.
- Q84284316 description "vitskapeleg artikkel" @default.
- Q84284316 description "vědecký článek" @default.
- Q84284316 description "wetenschappelijk artikel" @default.
- Q84284316 description "wissenschaftlicher Artikel" @default.
- Q84284316 description "επιστημονικό άρθρο" @default.
- Q84284316 description "мақолаи илмӣ" @default.
- Q84284316 description "наукова стаття, опублікована в червні 2012" @default.
- Q84284316 description "научна статия" @default.
- Q84284316 description "научная статья" @default.
- Q84284316 description "научни чланак" @default.
- Q84284316 description "научни чланак" @default.
- Q84284316 description "מאמר מדעי" @default.
- Q84284316 description "مقالة علمية نشرت في يونيو 2012" @default.
- Q84284316 description "জুন ২০১২-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ" @default.
- Q84284316 description "บทความทางวิทยาศาสตร์" @default.
- Q84284316 description "სამეცნიერო სტატია" @default.
- Q84284316 name "Intravenous golimumab is effective in patients with active rheumatoid arthritis despite methotrexate therapy with responses as early as week 2: results of the phase 3, randomised, multicentre, double-blind, placebo-controlled GO-FURTHER trial" @default.
- Q84284316 name "Intravenous golimumab is effective in patients with active rheumatoid arthritis despite methotrexate therapy with responses as early as week 2: results of the phase 3, randomised, multicentre, double-blind, placebo-controlled GO-FURTHER trial" @default.
- Q84284316 type Item @default.
- Q84284316 label "Intravenous golimumab is effective in patients with active rheumatoid arthritis despite methotrexate therapy with responses as early as week 2: results of the phase 3, randomised, multicentre, double-blind, placebo-controlled GO-FURTHER trial" @default.
- Q84284316 label "Intravenous golimumab is effective in patients with active rheumatoid arthritis despite methotrexate therapy with responses as early as week 2: results of the phase 3, randomised, multicentre, double-blind, placebo-controlled GO-FURTHER trial" @default.
- Q84284316 prefLabel "Intravenous golimumab is effective in patients with active rheumatoid arthritis despite methotrexate therapy with responses as early as week 2: results of the phase 3, randomised, multicentre, double-blind, placebo-controlled GO-FURTHER trial" @default.
- Q84284316 prefLabel "Intravenous golimumab is effective in patients with active rheumatoid arthritis despite methotrexate therapy with responses as early as week 2: results of the phase 3, randomised, multicentre, double-blind, placebo-controlled GO-FURTHER trial" @default.
- Q84284316 P1433 Q84284316-21AA58E2-7CCA-47F6-8152-BAF21D56FA0B @default.
- Q84284316 P1476 Q84284316-7F76D6DD-4568-4616-BC93-875F331884B0 @default.
- Q84284316 P2093 Q84284316-06BAAEAE-4841-4625-B714-2F0E72E25DD1 @default.
- Q84284316 P2093 Q84284316-14FEE3A1-0CE1-4D82-BC45-D0F162537264 @default.
- Q84284316 P2093 Q84284316-298C110D-DAE6-4CBB-9BC3-E02C69FC0878 @default.
- Q84284316 P2093 Q84284316-31993E43-2990-4630-B3DA-8BEC61FE08D6 @default.
- Q84284316 P2093 Q84284316-544D4EE2-001B-4CDF-AF3C-EFB5321DCC7D @default.
- Q84284316 P2093 Q84284316-B63E7DDB-B59E-40AF-8951-374780769730 @default.
- Q84284316 P2093 Q84284316-C0F86AC8-FCD5-420F-97A7-04185EEB0132 @default.
- Q84284316 P2093 Q84284316-E38DDA72-A588-423D-AB72-1B9CD0BABF59 @default.
- Q84284316 P304 Q84284316-29451E75-3C72-49E9-89BB-4B015D2C4749 @default.
- Q84284316 P31 Q84284316-7D409EE2-2551-41D2-9C37-F8BF23B6A82F @default.
- Q84284316 P356 Q84284316-104E9FB5-B43B-4F80-8798-2BDE3298CD38 @default.
- Q84284316 P433 Q84284316-6D05EC7F-4280-4FA7-9BD4-7C6573EB6A3D @default.
- Q84284316 P478 Q84284316-2F5CA5B8-5696-4E31-A1DE-C22099F640AF @default.
- Q84284316 P577 Q84284316-31F49ACD-4A2C-43CB-A40F-1D3236369F44 @default.
- Q84284316 P698 Q84284316-58844D03-9668-4D2D-B75B-AA33E4805B12 @default.
- Q84284316 P921 Q84284316-02E01E23-F0CF-4986-976D-42CBF28C7F7B @default.
- Q84284316 P921 Q84284316-701F6CE3-1893-4E8A-BDC9-8E7FD7E706F2 @default.
- Q84284316 P921 Q84284316-8A89863B-9736-4F69-9E04-344EF8487DD3 @default.
- Q84284316 P921 Q84284316-DA35D65C-465B-474F-9CD3-9AB21EBB5CAE @default.
- Q84284316 P921 Q84284316-E16DA5D7-3494-4F90-BB9D-111CF878C23A @default.
- Q84284316 P356 ANNRHEUMDIS-2012-201411 @default.
- Q84284316 P698 22661646 @default.
- Q84284316 P1433 Q4767876 @default.
- Q84284316 P1476 "Intravenous golimumab is effective in patients with active rheumatoid arthritis despite methotrexate therapy with responses as early as week 2: results of the phase 3, randomised, multicentre, double-blind, placebo-controlled GO-FURTHER trial" @default.
- Q84284316 P2093 "Alan M Mendelsohn" @default.
- Q84284316 P2093 "Clifton O Bingham" @default.
- Q84284316 P2093 "Daniel Baker" @default.
- Q84284316 P2093 "Jiandong Lu" @default.
- Q84284316 P2093 "Lilianne Kim" @default.
- Q84284316 P2093 "Michael E Weinblatt" @default.
- Q84284316 P2093 "Michael Mack" @default.
- Q84284316 P2093 "Rene Westhovens" @default.
- Q84284316 P304 "381-389" @default.